首页|差异表达微小核糖核酸在子宫内膜异位症中的诊断价值及调控机制

差异表达微小核糖核酸在子宫内膜异位症中的诊断价值及调控机制

扫码查看
目的 探讨差异表达微小核糖核酸(miR)在子宫内膜异位症(EMT)中的诊断价值,并分析其调控作用机制。方法 选取南京医科大学附属苏州医院妇产科2022年3月至2023年3月收治的EMT患者75例纳入EMT组,选取同期健康志愿者75名纳入正常对照组。通过miR芯片分析技术筛选研究对象血样中表达差异的miR,采用定量聚合酶链反应(qPCR)法检测75例EMT患者的血样及60例拟行手术的EMT患者术前1 d、术后2个月血样的miR-410-3p的表达水平,采用受试者工作特征(ROC)曲线分析miR-410-3p在EMT中的诊断价值,通过TargetScan数据库进行生物信息学分析筛选靶基因,采用双荧光素酶报告基因实验和免疫印迹(Western blot)法检测转染miR-410-3p后血管内皮生长因子A(VEGFA)的表达水平。结果 共筛选出87个表达差异的miRNA。与正常对照组比较,EMT组miR-365的表达显著上调(P<0。05),miR-410-3p的表达显著下调(P<0。05)。miR-410-3p的ROC曲线下面积(AUC)为0。770 5。60例拟行手术的EMT患者术前、术后血样验证发现,病灶切除后,miR-410-3p的表达显著上调(P<0。05)。转染miR-410-3p后,VEGFA表达显著下调(P<0。05)。结论 血浆miR-410-3p可作为EMT患者的生物标志物,可靶向调控VEGFA的表达,具有良好的诊断潜力,其可能通过靶向抑制VEGFA发挥调控作用。
Diagnostic Value and Regulatory Mechanism of Differentially Expressed miR in Endometriosis
Objective To investigate the diagnostic value of differentially expressed microRNA(miR)in endometriosis(EMT),and to analyze its regulatory mechanism.Methods A total of 75 patients with EMT admitted to the Obstetrics and Gynecology Department of the Affiliated Suzhou Hospital of Nanjing Medical University from March 2022 to March 2023 were selected as the EMT group,and 75 healthy volunteers were selected as the normal control group during the same period.The miR chip analysis technology was used to screen the differentially expressed miRNAs in the blood samples of the research subjects.Quantitative polymerase chain reaction(qPCR)was used to detect the expression levels of miR-410-3p in the blood samples of 75 EMT patients.Of which,blood samples of 60 EMT patients who were scheduled for surgery on the day before surgery and two months after surgery were also verified.The receiver operating characteristic(ROC)curve was used to analyze the diagnostic value of miR-410-3p in EMT.Bioinformatics analysis was carried out through the TargetScan database to screen target genes.Dual luciferase reporter gene assay and Western blot were used to detect the expression levels of transfection of miR-410-3p and the vascular endothelial growth factor A(VEGFA).Results A total of 87 differentially expressed miRs were screened out.Compared with those in the normal control group,the expression of miR-365 was significantly up-regulated in the EMT group(P<0.05),while the expression of miR-410-3p was significantly down-regulated in the EMT group(P<0.05).The area under the ROC curve(AUC)of miR-410-3p was 0.770 5.The verification test of preoperative and postoperative blood samples of 60 EMT patients who were scheduled for surgery showed that the expression of miR-410-3p was significantly up-regulated after lesion tissue resection(P<0.05).After transfection with miR-410-3p,the expression levels of VEGFA was significantly down-regulated(P<0.05).Conclusion Plasma miR-410-3p can target the regulation of VEGFA expression as a biomarker for EMT patients,and it has good diagnostic potential,which may exert regulatory effects by targeting the inhibition of VEGFA.

endometriosismicroRNAvascular endothelial growth factor Adiagnostic valueregulatory mechanism

李甘、徐颖、王峰、陆晓凡、杨渊

展开 >

南京医科大学附属苏州医院·江苏省苏州市立医院,江苏苏州 215008

第一三共<中国>投资有限公司,上海 200040

子宫内膜异位症 微小核糖核酸 血管内皮生长因子A 诊断价值 调控机制

江苏省苏州市科技发展计划项目江苏省苏州市科技发展计划项目江苏省苏州市科技发展计划项目

SYSD2020192SKJYD2021169SKJY2021120

2024

中国药业
重庆市食品药品监督管理局

中国药业

CSTPCD
影响因子:1.369
ISSN:1006-4931
年,卷(期):2024.33(17)